The global market for PD-1 and PD-L1 Monoclonal Antibodies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

According to the different tumor immune mechanisms, the most studied immunotherapy currently mainly includes cellular immunotherapy and immune checkpoint inhibitor therapy. Among them, the immune checkpoint inhibitor that can be used clinically has cytotoxic T lymphocyte-associated antigen 4 (cytotoxic T lymphocyte-associated antigen 4). " lymphocyte associated antigen-4, CTLA-4) and programmed cell death protein-1 (programmed cell death protein-1, PD-1)/programmed cell death-ligand 1 (programmed cell death-ligand 1, PD- L1). This report studies PD-1 and PD-L1 monoclonal antibodies.

North American market for PD-1 and PD-L1 Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for PD-1 and PD-L1 Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for PD-1 and PD-L1 Monoclonal Antibodies in Lung Cancer Treatment is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of PD-1 and PD-L1 Monoclonal Antibodies include Merck, Bristol-Myers Squibb, Roche, Pfizer, Astrazeneca, Novartis, Biocad, Sanofi/Regeneron Pharmaceuticals, Beigene, Jiangsu Hengrui Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for PD-1 and PD-L1 Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-1 and PD-L1 Monoclonal Antibodies.

The PD-1 and PD-L1 Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PD-1 and PD-L1 Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PD-1 and PD-L1 Monoclonal Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of PD-1 and PD-L1 Monoclonal Antibodies Market Report

Report Metric	Details
Report Name	PD-1 and PD-L1 Monoclonal Antibodies Market
Segment by Type	PD-1 Monoclonal Antibody PD-L1 Monoclonal Antibody
Segment by Application	Lung Cancer Treatment Melanoma Treatment Bowel Cancer Treatment Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Bristol-Myers Squibb, Roche, Pfizer, Astrazeneca, Novartis, Biocad, Sanofi/Regeneron Pharmaceuticals, Beigene, Jiangsu Hengrui Pharmaceuticals, Innovent Biologics, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PD-1 and PD-L1 Monoclonal Antibodies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the PD-1 and PD-L1 Monoclonal Antibodies Market report?

Ans: The main players in the PD-1 and PD-L1 Monoclonal Antibodies Market are Merck, Bristol-Myers Squibb, Roche, Pfizer, Astrazeneca, Novartis, Biocad, Sanofi/Regeneron Pharmaceuticals, Beigene, Jiangsu Hengrui Pharmaceuticals, Innovent Biologics, Inc.

What are the Application segmentation covered in the PD-1 and PD-L1 Monoclonal Antibodies Market report?

Ans: The Applications covered in the PD-1 and PD-L1 Monoclonal Antibodies Market report are Lung Cancer Treatment, Melanoma Treatment, Bowel Cancer Treatment, Other

What are the Type segmentation covered in the PD-1 and PD-L1 Monoclonal Antibodies Market report?

Ans: The Types covered in the PD-1 and PD-L1 Monoclonal Antibodies Market report are PD-1 Monoclonal Antibody, PD-L1 Monoclonal Antibody

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PD-1 and PD-L1 Monoclonal Antibodies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 PD-1 Monoclonal Antibody

1.2.3 PD-L1 Monoclonal Antibody

1.3 Market by Application

1.3.1 Global PD-1 and PD-L1 Monoclonal Antibodies Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Lung Cancer Treatment

1.3.3 Melanoma Treatment

1.3.4 Bowel Cancer Treatment

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global PD-1 and PD-L1 Monoclonal Antibodies Market Perspective (2020-2031)

2.2 Global PD-1 and PD-L1 Monoclonal Antibodies Growth Trends by Region

2.2.1 Global PD-1 and PD-L1 Monoclonal Antibodies Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 PD-1 and PD-L1 Monoclonal Antibodies Historic Market Size by Region (2020-2025)

2.2.3 PD-1 and PD-L1 Monoclonal Antibodies Forecasted Market Size by Region (2026-2031)

2.3 PD-1 and PD-L1 Monoclonal Antibodies Market Dynamics

2.3.1 PD-1 and PD-L1 Monoclonal Antibodies Industry Trends

2.3.2 PD-1 and PD-L1 Monoclonal Antibodies Market Drivers

2.3.3 PD-1 and PD-L1 Monoclonal Antibodies Market Challenges

2.3.4 PD-1 and PD-L1 Monoclonal Antibodies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top PD-1 and PD-L1 Monoclonal Antibodies Players by Revenue

3.1.1 Global Top PD-1 and PD-L1 Monoclonal Antibodies Players by Revenue (2020-2025)

3.1.2 Global PD-1 and PD-L1 Monoclonal Antibodies Revenue Market Share by Players (2020-2025)

3.2 Global PD-1 and PD-L1 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by PD-1 and PD-L1 Monoclonal Antibodies Revenue

3.4 Global PD-1 and PD-L1 Monoclonal Antibodies Market Concentration Ratio

3.4.1 Global PD-1 and PD-L1 Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PD-1 and PD-L1 Monoclonal Antibodies Revenue in 2024

3.5 Global Key Players of PD-1 and PD-L1 Monoclonal Antibodies Head office and Area Served

3.6 Global Key Players of PD-1 and PD-L1 Monoclonal Antibodies, Product and Application

3.7 Global Key Players of PD-1 and PD-L1 Monoclonal Antibodies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 PD-1 and PD-L1 Monoclonal Antibodies Breakdown Data by Type

4.1 Global PD-1 and PD-L1 Monoclonal Antibodies Historic Market Size by Type (2020-2025)

4.2 Global PD-1 and PD-L1 Monoclonal Antibodies Forecasted Market Size by Type (2026-2031)

5 PD-1 and PD-L1 Monoclonal Antibodies Breakdown Data by Application

5.1 Global PD-1 and PD-L1 Monoclonal Antibodies Historic Market Size by Application (2020-2025)

5.2 Global PD-1 and PD-L1 Monoclonal Antibodies Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America PD-1 and PD-L1 Monoclonal Antibodies Market Size (2020-2031)

6.2 North America PD-1 and PD-L1 Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2020-2025)

6.4 North America PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe PD-1 and PD-L1 Monoclonal Antibodies Market Size (2020-2031)

7.2 Europe PD-1 and PD-L1 Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2020-2025)

7.4 Europe PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibodies Market Size (2020-2031)

8.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibodies Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibodies Market Size by Region (2020-2025)

8.4 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibodies Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America PD-1 and PD-L1 Monoclonal Antibodies Market Size (2020-2031)

9.2 Latin America PD-1 and PD-L1 Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2020-2025)

9.4 Latin America PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibodies Market Size (2020-2031)

10.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2020-2025)

10.4 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.1.4 Merck Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Bristol-Myers Squibb

11.2.1 Bristol-Myers Squibb Company Details

11.2.2 Bristol-Myers Squibb Business Overview

11.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.2.4 Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.2.5 Bristol-Myers Squibb Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.3.4 Roche Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.3.5 Roche Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.4.4 Pfizer Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Astrazeneca

11.5.1 Astrazeneca Company Details

11.5.2 Astrazeneca Business Overview

11.5.3 Astrazeneca PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.5.4 Astrazeneca Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.5.5 Astrazeneca Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.6.4 Novartis Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 Biocad

11.7.1 Biocad Company Details

11.7.2 Biocad Business Overview

11.7.3 Biocad PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.7.4 Biocad Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.7.5 Biocad Recent Development

11.8 Sanofi/Regeneron Pharmaceuticals

11.8.1 Sanofi/Regeneron Pharmaceuticals Company Details

11.8.2 Sanofi/Regeneron Pharmaceuticals Business Overview

11.8.3 Sanofi/Regeneron Pharmaceuticals PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.8.4 Sanofi/Regeneron Pharmaceuticals Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.8.5 Sanofi/Regeneron Pharmaceuticals Recent Development

11.9 Beigene

11.9.1 Beigene Company Details

11.9.2 Beigene Business Overview

11.9.3 Beigene PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.9.4 Beigene Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.9.5 Beigene Recent Development

11.10 Jiangsu Hengrui Pharmaceuticals

11.10.1 Jiangsu Hengrui Pharmaceuticals Company Details

11.10.2 Jiangsu Hengrui Pharmaceuticals Business Overview

11.10.3 Jiangsu Hengrui Pharmaceuticals PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.10.4 Jiangsu Hengrui Pharmaceuticals Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.10.5 Jiangsu Hengrui Pharmaceuticals Recent Development

11.11 Innovent Biologics, Inc.

11.11.1 Innovent Biologics, Inc. Company Details

11.11.2 Innovent Biologics, Inc. Business Overview

11.11.3 Innovent Biologics, Inc. PD-1 and PD-L1 Monoclonal Antibodies Introduction

11.11.4 Innovent Biologics, Inc. Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

11.11.5 Innovent Biologics, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi Regeneron Pharmaceuticals

BeiGene Ltd

Jiangsu Hengrui Pharmaceuticals

Innovent Biologics, Inc.

List of Tables

Table 1. Global PD-1 and PD-L1 Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of PD-1 Monoclonal Antibody

Table 3. Key Players of PD-L1 Monoclonal Antibody

Table 4. Global PD-1 and PD-L1 Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global PD-1 and PD-L1 Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global PD-1 and PD-L1 Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global PD-1 and PD-L1 Monoclonal Antibodies Market Share by Region (2020-2025)

Table 8. Global PD-1 and PD-L1 Monoclonal Antibodies Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global PD-1 and PD-L1 Monoclonal Antibodies Market Share by Region (2026-2031)

Table 10. PD-1 and PD-L1 Monoclonal Antibodies Market Trends

Table 11. PD-1 and PD-L1 Monoclonal Antibodies Market Drivers

Table 12. PD-1 and PD-L1 Monoclonal Antibodies Market Challenges

Table 13. PD-1 and PD-L1 Monoclonal Antibodies Market Restraints

Table 14. Global PD-1 and PD-L1 Monoclonal Antibodies Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global PD-1 and PD-L1 Monoclonal Antibodies Market Share by Players (2020-2025)

Table 16. Global Top PD-1 and PD-L1 Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Monoclonal Antibodies as of 2024)

Table 17. Ranking of Global Top PD-1 and PD-L1 Monoclonal Antibodies Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by PD-1 and PD-L1 Monoclonal Antibodies Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of PD-1 and PD-L1 Monoclonal Antibodies, Headquarters and Area Served

Table 20. Global Key Players of PD-1 and PD-L1 Monoclonal Antibodies, Product and Application

Table 21. Global Key Players of PD-1 and PD-L1 Monoclonal Antibodies, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global PD-1 and PD-L1 Monoclonal Antibodies Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global PD-1 and PD-L1 Monoclonal Antibodies Revenue Market Share by Type (2020-2025)

Table 25. Global PD-1 and PD-L1 Monoclonal Antibodies Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global PD-1 and PD-L1 Monoclonal Antibodies Revenue Market Share by Type (2026-2031)

Table 27. Global PD-1 and PD-L1 Monoclonal Antibodies Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global PD-1 and PD-L1 Monoclonal Antibodies Revenue Market Share by Application (2020-2025)

Table 29. Global PD-1 and PD-L1 Monoclonal Antibodies Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global PD-1 and PD-L1 Monoclonal Antibodies Revenue Market Share by Application (2026-2031)

Table 31. North America PD-1 and PD-L1 Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe PD-1 and PD-L1 Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibodies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibodies Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America PD-1 and PD-L1 Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 46. Merck Company Details

Table 47. Merck Business Overview

Table 48. Merck PD-1 and PD-L1 Monoclonal Antibodies Product

Table 49. Merck Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 50. Merck Recent Development

Table 51. Bristol-Myers Squibb Company Details

Table 52. Bristol-Myers Squibb Business Overview

Table 53. Bristol-Myers Squibb PD-1 and PD-L1 Monoclonal Antibodies Product

Table 54. Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 55. Bristol-Myers Squibb Recent Development

Table 56. Roche Company Details

Table 57. Roche Business Overview

Table 58. Roche PD-1 and PD-L1 Monoclonal Antibodies Product

Table 59. Roche Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 60. Roche Recent Development

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer PD-1 and PD-L1 Monoclonal Antibodies Product

Table 64. Pfizer Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. Astrazeneca Company Details

Table 67. Astrazeneca Business Overview

Table 68. Astrazeneca PD-1 and PD-L1 Monoclonal Antibodies Product

Table 69. Astrazeneca Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 70. Astrazeneca Recent Development

Table 71. Novartis Company Details

Table 72. Novartis Business Overview

Table 73. Novartis PD-1 and PD-L1 Monoclonal Antibodies Product

Table 74. Novartis Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 75. Novartis Recent Development

Table 76. Biocad Company Details

Table 77. Biocad Business Overview

Table 78. Biocad PD-1 and PD-L1 Monoclonal Antibodies Product

Table 79. Biocad Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 80. Biocad Recent Development

Table 81. Sanofi/Regeneron Pharmaceuticals Company Details

Table 82. Sanofi/Regeneron Pharmaceuticals Business Overview

Table 83. Sanofi/Regeneron Pharmaceuticals PD-1 and PD-L1 Monoclonal Antibodies Product

Table 84. Sanofi/Regeneron Pharmaceuticals Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 85. Sanofi/Regeneron Pharmaceuticals Recent Development

Table 86. Beigene Company Details

Table 87. Beigene Business Overview

Table 88. Beigene PD-1 and PD-L1 Monoclonal Antibodies Product

Table 89. Beigene Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 90. Beigene Recent Development

Table 91. Jiangsu Hengrui Pharmaceuticals Company Details

Table 92. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 93. Jiangsu Hengrui Pharmaceuticals PD-1 and PD-L1 Monoclonal Antibodies Product

Table 94. Jiangsu Hengrui Pharmaceuticals Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 95. Jiangsu Hengrui Pharmaceuticals Recent Development

Table 96. Innovent Biologics, Inc. Company Details

Table 97. Innovent Biologics, Inc. Business Overview

Table 98. Innovent Biologics, Inc. PD-1 and PD-L1 Monoclonal Antibodies Product

Table 99. Innovent Biologics, Inc. Revenue in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 100. Innovent Biologics, Inc. Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. PD-1 and PD-L1 Monoclonal Antibodies Picture

Figure 2. Global PD-1 and PD-L1 Monoclonal Antibodies Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global PD-1 and PD-L1 Monoclonal Antibodies Market Share by Type: 2024 VS 2031

Figure 4. PD-1 Monoclonal Antibody Features

Figure 5. PD-L1 Monoclonal Antibody Features

Figure 6. Global PD-1 and PD-L1 Monoclonal Antibodies Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global PD-1 and PD-L1 Monoclonal Antibodies Market Share by Application: 2024 VS 2031

Figure 8. Lung Cancer Treatment Case Studies

Figure 9. Melanoma Treatment Case Studies

Figure 10. Bowel Cancer Treatment Case Studies

Figure 11. Other Case Studies

Figure 12. PD-1 and PD-L1 Monoclonal Antibodies Report Years Considered

Figure 13. Global PD-1 and PD-L1 Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global PD-1 and PD-L1 Monoclonal Antibodies Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global PD-1 and PD-L1 Monoclonal Antibodies Market Share by Region: 2024 VS 2031

Figure 16. Global PD-1 and PD-L1 Monoclonal Antibodies Market Share by Players in 2024

Figure 17. Global Top PD-1 and PD-L1 Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Monoclonal Antibodies as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by PD-1 and PD-L1 Monoclonal Antibodies Revenue in 2024

Figure 19. North America PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America PD-1 and PD-L1 Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 21. United States PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe PD-1 and PD-L1 Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 25. Germany PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibodies Market Share by Region (2020-2031)

Figure 33. China PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America PD-1 and PD-L1 Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 41. Mexico PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 45. Turkey PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE PD-1 and PD-L1 Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Merck Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 49. Bristol-Myers Squibb Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 50. Roche Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 52. Astrazeneca Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 54. Biocad Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 55. Sanofi/Regeneron Pharmaceuticals Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 56. Beigene Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 57. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 58. Innovent Biologics, Inc. Revenue Growth Rate in PD-1 and PD-L1 Monoclonal Antibodies Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions